Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders

Vittoria Pagliarini, Claudio Sette, Piergiorgio La Rosa

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

10 Citazioni (Scopus)


Alternative splicing is a powerful mechanism that largely expands the coding potential of eukaryotic genomes. Indeed, its complex and flexible regulation is exploited by cells to adapt to various environmental conditions, through production of protein variants displaying different functions. Such flexibility, however, is accompanied by high risk of errors, and dysregulation of splicing is now recognized as an important factor in human diseases. Notably, the RNA-based nature of splicing, which involves high specificity through base pair recognition, offers a remarkable therapeutic opportunity by allowing design of tools with elevated target selectivity. Herein, we illustrate examples of how defective splicing, obtained by mutations affecting multiple layers of regulation, can result in pathology. In particular, we focus on splicing-related defects occurring in brain and muscle diseases and describe therapeutic approaches currently available for these pathologies.
Lingua originaleEnglish
pagine (da-a)1215-1235
Numero di pagine21
RivistaHuman Genetics
Stato di pubblicazionePubblicato - 2017


  • Amyotrophic Lateral Sclerosis
  • Amyotrophic Lateral Sclerosis Patient
  • Animals
  • Autism Spectrum Disorder
  • Brain Diseases
  • Duchenne Muscular Dystrophy
  • Genetics
  • Genetics (clinical)
  • Humans
  • Muscular Diseases
  • RNA Splicing
  • Spinal Muscular Atrophy


Entra nei temi di ricerca di 'Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders'. Insieme formano una fingerprint unica.

Cita questo